Related Experiment Video

Updated: Nov 10, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.9K

A Farnesyltransferase Inhibitor Shows Efficacy in HRAS-Mutant HNSCC

    Cancer Discovery
    |April 3, 2021
    PubMed

    Insights

    Tipifarnib showed positive results in patients with head-and-neck squamous-cell carcinoma. This study highlights tipifarnib as a potential treatment option for this challenging cancer.

    Area of Science:

    • Oncology
    • Pharmacology

    Background:

    • Head-and-neck squamous-cell carcinoma (HNSCC) is a significant global health concern.
    • Existing treatments for HNSCC have limitations, necessitating novel therapeutic approaches.

    Purpose of the Study:

    • To evaluate the efficacy of tipifarnib in patients diagnosed with head-and-neck squamous-cell carcinoma.

    Main Methods:

    • Clinical trial involving patients with HNSCC treated with tipifarnib.
    • Response assessment based on established oncological criteria.

    Main Results:

    • Tipifarnib demonstrated notable responses in the patient cohort.
    • Specific response rates and duration of response were observed.

    Conclusions:

    • Tipifarnib exhibits therapeutic potential for head-and-neck squamous-cell carcinoma.
    • Further investigation into tipifarnib's role in HNSCC treatment is warranted.

    More Related Videos

    Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein07:08

    Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein

    Published on: January 16, 2020

    5.9K
    In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System05:45

    In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System

    Published on: January 9, 2020

    8.2K

    Related Concept Videos

    The Ras Gene02:38

    The Ras Gene

    The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
    Ras is a...
    6.7K
    Abnormal Proliferation02:23

    Abnormal Proliferation

    Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
    4.8K